These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32982225)

  • 1. TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors.
    Song S; Gui L; Feng Q; Taledaohan A; Li Y; Wang W; Wang Y; Wang Y
    Int J Nanomedicine; 2020; 15():6659-6671. PubMed ID: 32982225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.
    Wang Y; Li P; Wang S; Hu J; Chen XA; Wu J; Fisher M; Oshaben K; Zhao N; Gu Y; Wang D; Chen G; Wang Y
    J Biol Chem; 2012 Jul; 287(31):25941-53. PubMed ID: 22605338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells.
    Chen H; Wei L; Luo M; Wang X; Zhan Y; Mao Y; Huang C; Li J; Lu H
    Environ Toxicol; 2021 Nov; 36(11):2291-2301. PubMed ID: 34363436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
    Hu C; Chen X; Huang Y; Chen Y
    Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia.
    Liang Y; Pan B; Alam HB; Deng Q; Wang Y; Chen E; Liu B; Tian Y; Williams AM; Duan X; Wang Y; Zhang J; Li Y
    Eur J Pharmacol; 2018 Aug; 833():432-440. PubMed ID: 29981294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
    Huang W; Xing Y; Zhu L; Zhuo J; Cai M
    Exp Cell Res; 2021 Sep; 406(1):112633. PubMed ID: 34089726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold Nanoparticles Biosynthesized and Functionalized Using a Hydroxylated Tetraterpenoid Trigger Gene Expression Changes and Apoptosis in Cancer Cells.
    Tian B; Li J; Pang R; Dai S; Li T; Weng Y; Jin Y; Hua Y
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):37353-37363. PubMed ID: 30295457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis.
    Jia Y; Taledaohan A; Jia R; Wang X; Jia Y; Liu J; Wang Y
    Biomed Pharmacother; 2023 Dec; 168():115826. PubMed ID: 37931514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles.
    Tummala S; Kumar MN; Pindiprolu SK
    Drug Deliv; 2016 Nov; 23(9):3505-3519. PubMed ID: 27295176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.
    Li M; Lin C; Deng H; Strnad J; Bernabei L; Vogl DT; Burke JJ; Nefedova Y
    Mol Cancer Ther; 2020 Jul; 19(7):1530-1538. PubMed ID: 32371579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation.
    Yuan L; Zhang F; Qi X; Yang Y; Yan C; Jiang J; Deng J
    J Nanobiotechnology; 2018 Jul; 16(1):55. PubMed ID: 29996877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of intracellular delivery of anti-cancer drugs by the Tat peptide.
    Zhao JF; Chen JY; Mi L; Wang PN; Peng Q
    Ultrastruct Pathol; 2011 May; 35(3):119-23. PubMed ID: 21405950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA.
    Dong S; Zhou X; Yang J
    Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy.
    Hao X; Yan Q; Zhao J; Wang W; Huang Y; Chen Y
    PLoS One; 2015; 10(9):e0138911. PubMed ID: 26405806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
    Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
    Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Effect of Zwitterions of Imidazolium Derived from
    Vargas-Castro KC; Puebla Pérez AM; Rangel-Salas II; Delgado-Saucedo JI; Pelayo-Vázquez JB; Becerra-Martínez E; Peregrina-Lucano AA; Quiñonez-Lopez RR; Soltero-Reynoso GJ; Cortes-Llamas SA
    Med Chem; 2021; 17(1):33-39. PubMed ID: 31808388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAT-Modified Gold Nanoparticle Carrier with Enhanced Anticancer Activity and Size Effect on Overcoming Multidrug Resistance.
    Wang RH; Bai J; Deng J; Fang CJ; Chen X
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5828-5837. PubMed ID: 28124900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
    Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
    Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.